Keyphrases
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
20%
Bone Marrow
20%
Cytarabine
20%
Diagnostic Bones
20%
Genetic Aberrations
20%
High Risk
20%
High-dose Chemotherapy
20%
Highly Aggressive
20%
Ki-67
20%
Lymphoma Patients
100%
Lymphoma Therapy
20%
Mantle Cell Lymphoma
100%
No Response
20%
Notch1
20%
Novel Agents
20%
P53 Status
20%
Poor Response
20%
Prognostic Value
20%
Recent Advances
20%
Rituximab
20%
Standard of Care
40%
TP53 mutation
100%
Tumor Protein p53 (TP53)
40%
Univariate Model
20%
Young Patients
20%
Nursing and Health Professions
Diagnosis
20%
Drug Megadose
20%
Health Care Quality
40%
Mantle Cell Lymphoma
100%
Rituximab
20%
Transplantation
20%
Medicine and Dentistry
Cytarabine
20%
Diagnosis
20%
High Dose Chemotherapy
20%
Mantle Cell Lymphoma
100%
Rituximab
20%
Stem Cell Transplant
20%
